Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

January 31, 2019

Conditions
Chronic Pain
Interventions
DRUG

Amitriptyline

25 mg / day for 10 days

DRUG

Tolterodine

Placebo 1 mg / day for 10 days

Trial Locations (1)

3010

Dep. of Anesthesiology, Bern University Hospital, Bern

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

Aalborg University

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02256956 - Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II | Biotech Hunter | Biotech Hunter